Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients
- 26 June 1998
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 250 (1) , 69-71
- https://doi.org/10.1016/s0304-3940(98)00453-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Butyrylcholinesterase in the life cycle of amyloid plaquesAnnals of Neurology, 1997
- Synergy Between the Genes for Butyrylcholinesterase K Variant and Apolipoprotein E4 in Late-Onset Confirmed Alzheimer's DiseaseHuman Molecular Genetics, 1997
- Detection of the Plasma Cholinesterase K Variant by PCR Using an Amplification-Created Restriction SiteHuman Heredity, 1996
- A4POE*4-associated Alzheimer's disease risk is modified by α1–antichymotrypsin polymorphismNature Genetics, 1995
- Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementiaAnnals of Neurology, 1994
- Ultrastructural localization of butyrylcholinesterase on neurofibrillary degeneration sites in the brains of aged and Alzheimer's disease patientsBrain Research, 1994
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Cholinesterases regulate neurite growth of chick nerve cells in vitro by means of a non-enzymatic mechanismCell and tissue research, 1993
- Molecular Forms of Acetylcholinesterase and Butyrylcholinesterase in the Aged Human Central Nervous SystemJournal of Neurochemistry, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984